To allay FTC concerns, Bristol-Myers to sell Celgene psoriasis treatment By: New York Business Journal via Business Journals June 24, 2019 at 10:04 AM EDT The sale of Celgene's Otezla will "allow the transaction to close on a timely basis," Bristol-Myers Squibb said. Read More >>
